who observed the ecological association of high rates of cerebral hemorrhage with low average blood cholesterol levels in their populations.' Later, they noted a decreasing trend in stroke incidence rates over the years as mean population TC levels rose and blood pressure levels fell.2'3 Correlations were also found in individuals between low TC level and risk of cerebral hemorrhage in Japan,4-7 Honolulu,8'9 and Multiple Risk Factor Intervention Trial (MRFIT) screenee10 cohorts. The issue was independently raised by observations of greater colon cancer risk in individuals having low TC levels within high-average TC societies in some studies1l-13 but not in others. [14] [15] [16] More recently, greater noncardiovascular disease (non-CVD) risk was observed in those having low TC levels.17 In addition, the finding of excess non-CVD events and deaths among treated cohorts in several TC-lowering trials18-25 but not in other single or multifactor intervention trials26-30 has contributed to a renewed discussion about the possible health effects of low or of therapeutic lowering of TC levels. Finally, ecological studies suggest that populations having low average TC values (notably Japan) usually do not have excess cancer, non-CVD mortality, or total death rates, although they may have excess rates of hemorrhagic stroke.3' Public campaigns are now under way in industrialized countries to reduce elevated population mean levels of TC and low density lipoprotein (LDL) cholesterol, based on congruent evidence about their determining influence on both population and individual risk of atherosclerosis and epidemic coronary heart disease.32 '33 If these programs were to have any adverse effects, the nature and magnitude of such effects should be understood so that they can be avoided or minimized. Moreover, the scientific questions raised by the apparent non-CVD disease associations with low TC levels34 could lead to new insights on general issues of diet and health and on the larger role of cholesterol in human biology.
Issues related to risks of elevated blood cholesterol and the costs and benefits of cholesterol lowering were addressed in other recent NHLBI conferences, on "Cholesterol and Heart Disease in Older Persons and Women"35 and "Cost and Health Implications of Cholesterol Lowering". 36 The question of possible associations of low TC levels with cancer was addressed in a 1981 conference37 sponsored by the NHLBI in which inconsistent evidence had led to concern of a possible increase in cancer risk at very low cholesterol levels (<180 mg/dl) in men. 38 Because the magnitude of this risk was generally modest when present, the panelists concluded that "the findings do not represent a public health challenge; however, they do present a scientific challenge. "37 In the 1990 NHLBI conference, the investigators reported analyses on associations between low TC levels and disease in individual cohorts and in pooled data. Population (ecological) correlations were also presented along with a meta-analysis of clinical trials of TC lowering. Discussions were directed to the evidence about risk of specific diseases associated with low TC values including hemorrhagic stroke, cancers, and other diseases and with high TC values including coronary heart disease (CHD) and brain infarction. Potential mechanisms for the effects on disease or function of low blood or cell membrane cholesterol content were discussed, based on Effects of disease on blood cholesterol levels were also discussed, and the lack of information on lipoprotein subfractions was acknowledged. Finally, a panel recommended needs and opportunities for further research. Methods A summary analysis was carried out under the direction of Dr. Jacobs on data from 19 of 20 cohort studies invited to participate in the conference. A manuscript from the 20th study was shared with the study organizers.39 Table 1 enumerates the studies and includes 11 from the United States,8-'0"6'40-57 one from southern Europe,58 one from Israel,59-6' two from Great Britain,17,62-65 one from Scandinavia, and three from Japan."2,5-7,6667 The Scandinavian study (NORA) represents pooled data from five studies. Length of follow-up ranged from 9 to 30 years. Data were analyzed at each study center following a standard protocol developed at the University of Minnesota, where the pooled estimates were subsequently computed; data for individual participants were not available at the University of Minnesota. Data presented as part of the overview had not been published before conference presentation. The statistical overview itself had strengths and limitations that are reviewed in a later section herein. Table 2 gives for each study, separately for men and women, the numbers at risk and numbers of total deaths, as well as deaths among those with TC level <160 mg/dl. Of a total of 68,406 deaths in all the studies, approximately 45% were coded to total cardiovascular causes (ICD 9, 390-459), 33% to total cancer causes (ICD 9, 140-239) and 22% to non-CVD, noncancer causes. The latter category included respiratory (ICD 9, 460-519), digestive (ICD 9, 520-579), traumatic (ICD 9, 800-999), and other causes (ICD 9, 1-139, 240-389, and 580-799), comprising 5%, 4%, 6%, and 7% of total mortality, respectively. The distribution of causes of death is not presented by sex because numbers of deaths were not separated for each cause for all studies in materials submitted for the overview.
The proportional hazards regression model was used to study the relation of TC level to total mortality, total cardiovascular disease (CVD) mortality, total cancer mortality, and combined noncardiovascular, noncancer mortality for men and women separately, both unstratified and stratified by smoking or alcohol intake. Subcategories of cause of death-CHD, breast cancer, colon cancer, lung cancer, other cancers, respiratory disease, digestive disease, traumatic death, and all other causes-were studied separately for men and women. Separate regression coefficients for three TC classes (<160, 200-239, and .240 mg/dl) were computed for mortality risk relative to the class having TC levels mg/dl. The category 'TC< 160 mg/dl" was studied because there was some evidence that such low levels, even though rarely found in middle-aged persons in U.S. and European studies, might be associated with excess mortality risk. The other categories were selected to study changes in the TC: mortality relation as cholesterol increased. It was convenient to study people with TC>200 mg/dl and those with TC>240 mg/dl because of the role these levels play in the National Cholesterol Education Program. Hazard rate ratios were computed as the exponential of each regression coefficient. Differences among these hazard rate ratios the metabolic and physiological roles of cholesterol. Figure 1 and for the subcategories of noncardiovascular, noncancer causes in Figure 2 . Also given in Tables 3-7 ( Figure 1 ). In women, the pooled estimate of risk for all causes-death was essentially flat across TC levels (Table 3 and Figure 1 ).
Total Cardiovascular Death
In men whose entry TC levels were greater than the reference TC class 160-199 mg/dl, the estimated risk for total CVD death increased systematically and consistently (deaths in the 5 years after baseline excluded: Table 3 and Figure 1 ). Risk for men with TC level < 160 mg/dl, compared with those in the reference class, was (Table 3 ). The pooled estimated risk for total CVD death in women showed no trend across TC levels (Table 3 and Figure 1 ). In men, linear regression coefficients for TC and total CVD death were positive in the MRFIT and for 16 of 18 other studies (only Osaka and Hiroshima/Nagasaki had negative coefficients). In women, linear regression coefficients were positive in nine of 11 studies (only Tecumseh and Hiroshima/Nagasaki had negative coefficients).
Total Cancer Death
In men with TC level <160 mg/dl compared with 160-199 mg/dl, the risk ratio for total cancer deaths was greater than 1 in 15 of 18 studies; relative risk was 1.18 in the pooled studies and 1.23 in the MRFIT. The cancer risk ratio was close to 1 for classes of TC level >200 mg/dl (deaths in the 5 years after baseline excluded: Table 3 and Figure 1 ). In women, findings between studies were inconsistent; for example, total cancer death rate for those women having TC level < 160 mg/dl was greater than for those having TC level 160-199 mg/dl in six of 11 studies (Table 3) . In pooled data, there was little variation in women's risk for total cancer deaths across the four TC categories (Table 3 and Figure 1 ). In men, linear regression coefficients were negative in the MRFIT and in 14 of 18 other studies (only NORA, Tecumseh, Chicago Western Electric, and Whitehall had positive coefficients). In women, linear regression coefficients were negative in seven of 11 studies (only Tecumseh, NHEFS/NCHS, Akita, and Hiroshima/Nagasaki had positive coefficients).
Combined Non-CVD, Noncancer Death
Risk estimates for combined non-CVD, noncancer deaths in relation to TC level were similar from the MRFIT men, from all other men pooled, and from all women pooled. In both men and women, risk was consistently greater, by about 40%, for those having low TC levels (<160 mg/dl) compared with the reference class (TC level, 160-199 mg/dl). Figure 3 summarizes the hazard rate ratios among those with TC levels <160 mg/dl compared with those with TC level 160-199 mg/dl for combined non-CVD, noncancer death for individual studies, with each study indicated by its identifying number given in Table 1 . Consistency of excess risk in those with TC level <160 mg/dl is seen across studies, although most of the individual study estimates are not statistically significant. In both sexes, estimated risk was about 10% less than the reference class among those in TC class 200-239 mg/dl and was consistently less, by about 15%, in those men and women in the higher TC class .240 mg/dl (deaths in the 5 years after baseline excluded: Table 3 and Figure 1 ). In men, linear regression coefficients were negative in the MRFIT and in 15 of 18 other studies (only NORA, Framingham, and Chicago People's Gas had positive coefficients). In women, linear regression coefficients were negative in nine of 11 studies (only Akita and Osaka had positive coefficients). Effect on Relative Risk of Including Deaths in the First 5 Years
Pooled estimated hazard rate ratios were calculated to include early deaths (those occurring in the 5 years after baseline). Gradients of pooled estimated risk between TC categories are generally a few percent steeper than those in Table 3 .
Analyses Stratified by Alcohol Intake and Smoking
Pooled estimates of hazard rate ratios (deaths in the 5 years after baseline excluded) are presented for those with TC < 160 and for those with TC .240 (each versus the reference class of 160-199 mg/dl), stratified on alcohol drinking status (Table 4 ) and smoking habit (Table 5) . Not all studies provided these analyses. Puerto Rico and Yugoslavia estimates of hazard rate ratios for all drinkers combined were used in pooling data for both lighter and heavier drinkers. Stratification reduced the numbers at risk and rendered some estimates meaningless.
All causes, total CVD, total cancer and combined non-CVD, noncancer causes of death were studied. Relative risk for these four death outcomes were similar to the unstratified analysis of Table 3 for each stratum of drinking status (Table 4 ) and smoking status (Table 5) for both men and women. Note that there was very little information available concerning women who drank .30 ml/day of alcohol, particularly for TC< 160 mg/dl.
Subcategory Causes of Death
Pooled estimates of rate ratios for men and for women and estimates for the MRFIT men separately are presented for nine subcategory causes of death in Tables 6 and 7 and Figure 2 . Numbers of studies contributing information to the pooled estimates are indicated for each TC range. Some studies are omitted either because they did not provide these analyses or because a subcategory cause of death was rare.
Coronary and Other Cardiovascular Death CHD mortality rates increased consistently with increasing TC level in most studies (Table 6 ). The gradient of risk was steeper for the MRFIT than for the pooled estimates. Pooled estimates were slightly steeper for men than for women. Hemorrhagic stroke was not Table 6 was steeper than that for total cardiovascular disease in Table 3 . Therefore, the risk gradient across TC categories for non-CHD cardiovascular death was less steep than that for CHD death.
Cancer Death
Subcategory cancer deaths are considered in Figure 2 ). Pooled and MRFIT estimates of hazard rate ratios for respiratory disease death were > 1 for those with TC< 160 mg/dl and were progressively higher with lower TC level among the four categories considered here, suggesting a continuously negative graded risk. Digestive disease death rates showed a pattern of elevation at low TC levels and reduction at high TC levels, also suggesting a continuously graded risk. Death from trauma and from all residual causes showed excess estimated hazard rate ratios for men (pooled and MRFIT) and women with low TC (<160 mg/dl) but were little different from 1 at higher TC levels. The pooled estimated hazard rate ratio for traumatic death for women with TC<160 mg/dl was similar to that for men but had a higher variance and therefore a lower t value.
Consistency of Findings Across Studies
The extent of consistency of findings across the range of TC levels found in these studies is noteworthy in the similarity of findings for such disparate populations as Japan, the United States, and Europe, covering a wide range of average population TC levels and cultures. For example, noncardiovascular, noncancer mortality rates in men were elevated for those with TC< 160 mg/dl compared with those with TC 160-199 mg/dl in 13 of 14 U.S. and European studies (all except the Lipid Research Clinics study) as well as in the Osaka, Akita, and Hiroshima/Nagasaki studies in men (studies 12, 13, and 14 in Figure 3 ). In U.S. and European women, the Framingham and Paisley/Renfrew studies were the only two to show lower noncardiovascular, noncancer mortality rates at TC levels <160 mg/dl, whereas the NORA and NHEFS/NCHS studies showed no difference in noncardiovascular, noncancer mortality rates in women at TC levels < 160 versus 160-199 mg/dl. Elevated noncardiovascular, noncancer mortality rates were seen in the low TC class of two of three studies of Japanese women (Figure 3 ). This pattern was repeated in separate analyses of respiratory, digestive, traumatic, and all other deaths and was found more consistently in men than in women. Mortality rates were elevated for these Adjusted proportional hazards model hazard rate ratios. Adjusted for age, diastolic blood pressure, cigarette smoking, and body mass index, where available (see Table 1 ). See notes four death subcategories at low TC level for at least two of the three Japanese studies except for trauma in women, where the Akita study had insufficient information to contribute to the analysis. A finding of elevated mortality due to liver cancer, chronic hepatitis, cirrhosis, and nonmedical deaths at low TC levels has also been reported in a Chinese study of more than 9,000 Shanghai residents followed for 8-13 years,39 with mean TC level %160 mg/dl, with analyses of men and women combined, with regression dilution bias removed, and with adjustment for age, sex, diastolic blood pressure, cigarette smoking, and alcohol drinking status.
2.1
Total Mortality There is also evidence that among leukemia patients in remission after therapy, TC levels rise significantly.80 Dietary sources of fat and cholesterol strongly influence serum TC levels, and malabsorption syndromes are accompanied by low TC levels. Alcohol secreted in the lung may alter membrane integrity and cell function by inducing lipid changes and impairing surfactant secretion.81 Nevertheless, some studies69,82 found that elevated mortality at low levels of TC persisted even after the first 10 or more years of deaths were removed from analysis.
Because TC is measured with uncertainty due to both laboratory variation and true day-to-day biological variation, observed associations found between TC and deaths may be flatter than the true associations.83 Correction for regression dilution bias caused by withinperson error would be expected to result in steeper positive slope estimates, such as that for TC versus atherosclerotic disease deaths,84 and steeper negative slope estimates, such as that found in the overview for TC versus some other causes of death. The influence on the observation of TC: mortality relations of withinperson error in TC and in covariates should be studied further.
There was considerable conference discussion of the meaning of the overview analysis. An asset of the overview was considered to be the identification of 1 I I consistencies and inconsistencies between studies in low TC: mortality relations, including Japanese as well as U.S. and European studies. Identification of consistencies through examination of quantitative estimates of the magnitude of the statistical relations was thought to be particularly important in the study of low TC: mortality relations, where typical individual studies have low power.
Despite these contributions, the overview was hampered in several respects. For logistic reasons, namely that only two analysis requests could be filled (the second not by all the studies) before the conference, all desirable analyses could not be done, and, specifically, the underlying assumptions of the proportional hazards model could not be checked thoroughly. The major potential deviation from these assumptions would be failure of the proportionality assumption, for example, if the excess risk at low TC levels disappeared after a sufficiently long period after baseline. A A hypothesis that could not be addressed in analyses generated for this conference was that it may not be the absolute level of TC that matters but the position in the TC distribution. For example, genetic abnormalities of cell membranes (linked with their cholesterol content) might predominate in those who have a low cholesterol for their culture independent of absolute level of TC. Another interpretive difficulty, which follows from the fact that the observational studies were designed with hypotheses about CVD in mind, is the general absence of cohort data on morbidity and of data on factors that might confound the relations of low TC and noncardiovascular disease. Another possible problem is lack of comparability of TC measurements among studies. The pooled analysis gives estimates of TC-end point event relations within each study, before pooling, so that, for example, those with measured TC <160 mg/dl are compared with people in the same study with measured TC level between 160 and 199 mg/dl. If comparability of TC between studies were poor, the comparison of actual TC levels might be offset, for example, to <150 to 150-189 mg/dl in one study, and < 180 to 180-219 mg/dl in another.
For these reasons, there was general agreement among conference participants that the overview analfound of low TC and excess mortality were causal but were nevertheless important as guides for research.
Relation of Low TC to Death in Women
Many findings for women were discrepant from those for men. Of particular importance in women was considered to be the essentially flat relation of TC to total mortality, total CVD, and total cancer. Despite the lack of relation of TC to total CVD in women, it was noted that the relation of TC to CHD death was strong and positive in both sexes, in agreement with the findings of a previous meta-analysis. 35 However, women are less studied than men, and when findings for women were concordant with findings for men, they were at times more likely due to chance (e.g., for the relation of low TC to traumatic death). The conferees considered that biological differences between men and women might account for some of the sex differences in the associations. However, some of the ambiguities might be attributed to lack of power caused by the absence of a large cohort study in women analogous to the MRFIT Screening Study in men. It was suggested that studies should include women up to age 79 years to achieve comparable age-specific death rates to those in men, where studies used an age cutoff of 69 years. Further, the study of associations of disease with lipoprotein subfractions, not possible in this conference, is particularly pertinent in women because their HDL subfraction tends to be a relatively greater proportion of total lipoprotein than is the case in men.
Findings From Clinical Trials
Three studies85-87 with angiographic end points and several meta-analysesl81 2324 of randomized clinical trials show that TC lowering reduces the incidence of CHD. On the other hand, non-CVD death appears to be increased in those treated to lower TC, largely in single-factor primary prevention trials that used drug treatments. In contrast to these single-factor primary cholesterol-lowering trials, an excess in non-CHD deaths has been seen in only one of four multifactor intervention trials,25,27-30 and no excess was seen in several trials of secondary prevention.88 '89 At the conference, Yusuf presented an extension of an earlier meta-analysis of clinical trials of TC lowering.90 This extension involved 32 randomized clinical trials of TC lowering in over 42,000 individuals in which TC lowering reduced CHD incidence and mortality (p<O.OOl). The reduction in CHD was related to the "strength of the intervention" defined as degree of cholesterol lowering times duration of the study, with benefit seen in both dietary and drug trials and in primary and secondary prevention studies. On the other hand, in this meta-analysis of clinical trials, there was an excess of noncardiac deaths in treated compared with control groups. Yusuf Nutrients versus death rates. Average population nutrient intake was examined because of other evidence that diet determines the average TC level of populations (Table 8) . Associations of dietary components with subcategory causes of death among countries were based on per capita food disappearance data supplied by the United Nations Food and Agriculture Organization.3195-100 Ecological correlations with CHD death were positive for saturated fatty acids in men only and negative for monounsaturated fatty acids in both sexes. Ecological correlations between saturated or monounsaturated fatty acid intake and cancer death rates were positive in men and women except for stomach cancer, which was negative in both sexes. Stamler's analysis of data on nutrient intake from 20 countries is in agreement with findings in Table 8 
